User profiles for Yosu Luque

Yosu Luque

Sorbonne Université
Verified email at aphp.fr
Cited by 748

In vivo partial reprogramming alters age-associated molecular changes during physiological aging in mice

…, A Haghani, IG Guillen, S Sahu, C Wang, Y Luque… - Nature Aging, 2022 - nature.com
Partial reprogramming by expression of reprogramming factors (Oct4, Sox2, Klf4 and c-Myc)
for short periods of time restores a youthful epigenetic signature to aging cells and extends …

[HTML][HTML] The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor …

…, M Le Quintrec, G Jeantet, I Fumie, Y Luque… - Kidney international, 2020 - Elsevier
Ravulizumab is a long-acting C5 inhibitor engineered from eculizumab with increased
elimination half-life, allowing an extended dosing interval from two to eight weeks. Here we …

Vancomycin-associated cast nephropathy

Y Luque, K Louis, C Jouanneau, S Placier… - Journal of the …, 2017 - journals.lww.com
Vancomycin is a widely prescribed antibiotic, but the exact nature of vancomycin-associated
nephrotoxicity is unclear, in particular when considering the frequent coadministration of …

Administration of recombinant soluble urokinase receptor per se is not sufficient to induce podocyte alterations and proteinuria in mice

…, MC Verpont, S Vandermeersch, Y Luque… - Journal of the …, 2014 - journals.lww.com
Circulating levels of soluble forms of urokinase-type plasminogen activator receptor (suPAR)
are generally elevated in sera from children and adults with FSGS compared with levels in …

[HTML][HTML] Long-term efficacy and safety of the long-acting complement C5 inhibitor ravulizumab for the treatment of atypical hemolytic uremic syndrome in adults

…, S Cataland, K Garlo, N Heyne, Y Luque… - Kidney international …, 2021 - Elsevier
Introduction Atypical hemolytic uremic syndrome (aHUS) is a rare, complex, multisystem
disease of dysregulated complement activity, characterized by progressive thrombotic …

Causes of coma and their evolution in the medical intensive care unit

N Weiss, L Regard, C Vidal, Y Luque, G Taldir… - Journal of …, 2012 - Springer
Dear Sirs, Epidemiological data regarding the frequency of the different causes of coma and
their evolution over time in the ICU are scarce [1–4]. In the 1970s, Plum and Posner [2] …

[HTML][HTML] Vancomycin-associated tubular casts and vancomycin nephrotoxicity

N Tantranont, Y Luque, M Hsiao, C Haute… - Kidney international …, 2021 - Elsevier
Introduction Vancomycin nephrotoxicity is frequent and may be due to drug-induced acute
tubular necrosis (ATN) or tubulointerstitial nephritis (TIN). Vancomycin-associated tubular cast …

Nanometric chemical speciation of abnormal deposits in kidney biopsy: Infrared-nanospectroscopy reveals heterogeneities within vancomycin casts

E Esteve, Y Luque, J Waeytens, D Bazin… - Analytical …, 2020 - ACS Publications
Infrared (IR) spectromicroscopy allows chemical mapping of a kidney biopsy. It is particularly
interesting for chemical speciation of abnormal tubular deposits and calcification. In 2017, …

AIM2 suppresses inflammation and epithelial cell proliferation during glomerulonephritis

…, HD de Koning, B Petri, Y Luque… - The Journal of …, 2021 - journals.aai.org
Absent in melanoma-2 (AIM2) is an inflammasome-forming innate immune sensor for
dsDNA but also exhibits inflammasome-independent functions such as restricting cellular …

Nephronophthisis in young adults phenocopying thrombotic microangiopathy and severe nephrosclerosis

…, R Khayat, PA Michel, D Buob, Y Luque… - Clinical Journal of the …, 2021 - journals.lww.com
Severe hypertension revealing a CKD is a common situation in adult nephrology. Despite in-depth
etiologic investigations, uncontrolled hypertension is often retained as thefinal cause …